COLORADO: A 2021 survey finds a positive correlation between the number of COVID-19 cases and demand for medical cannabis; more than half of patients said they used cannabis “to feel happy.”
— 55% of medical cannabis patients primarily use to feel ‘happy’
— Patient desire to feel ‘happy’ via medical cannabis use grew 46% in the past year
— Study suggests exogenous shocks like COVID-19, elections, protests and riots positively influence medical cannabis demand
Did the stressors of COVID-19 drive more Americans to use medical cannabis as an alternative tool for managing their mental health? A new national study exploring this question found a positive correlation between national demand for medical cannabis and the national number of COVID-19 cases; in other words, as cases increased, so did medical cannabis use. And whereas the most common reason for obtaining a medical card has historically been for chronic pain, the majority of medical cannabis patients who applied for medical cards over the past year cited psychological purposes, with 55% of patients saying their main reason for using cannabis was “to feel ‘happy.”
These findings are part of a national study conducted by Veriheal, the healthcare enterprise behind the nation’s largest medical marijuana application platform, in partnership with graduate research scholars from the London School of Economics, University of Southern California and University of Maryland; and the CREA (Cultivating Research Education and Advocacy) Group, a business development and research firm dedicated to psychoactive drugs like cannabinoids, psychedelics, and entheogens. The findings were officially presented to the American Chemical Society, a congressionally chartered non-profit leading research in the global chemical enterprise, at their April 2021 national conference.
Conducted between January 2020 and March 2021, the study investigated medical cannabis interest and adoption by desired effect across region, sex and age group, in relation to COVID-19 cases in America as reported by the official COVID-19 CDC data tracker.
Patient data was obtained from surveys on the Veriheal telemedicine platform, which connects prospective cannabis patients to state-certified cannabis doctors to facilitate and streamline the medical marijuana (MMJ) card application process.